Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1986Journal of Clinical Oncology

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes.

View Full Paper
Ask AI
Bookmark
Share

Authors

BCBruce D. ChesonCenter for Cancer and Blood DisordersDJDorcie M. JasperseUniversity of the PotomacRSRichard SimonLeidos (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cheson et al. (1986) studied this question.

synapsesocial.com/papers/6a190f406298e9f701be35bfhttps://doi.org/10.1200/jco.1986.4.12.1857
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Therapeutic Trial with Low-Dose Cytarabine in Myelodysplastic Syndromes and Acute Leukemia2009 · 14 citations
  2. 2Low‐dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8‐trisomy: in vitro and in vivo evidence for normal haematopoietic recovery1985 · 18 citations
  3. 3Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.1985 · 75 citations
  4. 4Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia1985 · 70 citations
  5. 5FAVOURABLE REMISSION RATE BY REPEATING LOW DOSE ARA‐C TREATMENT IN ANLL AND RAEB1985 · 10 citations